Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques). (Q33370782)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques). |
scientific article |
Statements
1 reference
Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques). (English)
1 reference
Riggi M
1 reference
Ruffie P
1 reference
Voisin S
1 reference
Monnet I
1 reference
de Cremoux H
1 reference
Saltiel JC
1 reference
Martin M
1 reference
Vergne L
1 reference
Huet J
1 reference
Cvitkovic E
1 reference
1 January 1991
1 reference
1 reference
1238-1242
1 reference
Identifiers
1 reference
1 reference